Literature DB >> 2459958

Immunohistochemistry of estrogen receptor protein in paraffin sections. Effects of enzymatic pretreatment and cobalt chloride intensification.

O Hiort1, P W Kwan, R A DeLellis.   

Abstract

Monoclonal antibodies provide important tools for the demonstration of estrogen receptors (ERs) in cases of breast cancer. This study reports an improved immunohistochemical method for the demonstration of ER in formalin-fixed paraffin-embedded tissue samples using the Abbott monoclonal antibody to ER protein. Tissue sections were pretreated briefly with trypsin, followed by DNase before the performance of the immunohistochemical reaction and cobalt chloride was used to intensify the color of the diaminobenzidine reaction product. In 20 cases, the results in paraffin sections were compared with biochemical assays with the dextran-coated charcoal technique or with immunohistochemistry performed on frozen sections. There was an excellent correlation between the results obtained with all three methods. The introduction of cobalt chloride into the chromogen solution significantly increased the sensitivity of this approach as compared with the use of diaminobenzidine alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459958     DOI: 10.1093/ajcp/90.5.559

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas.

Authors:  C Doglioni; M Gambacorta; G Zamboni; G Coggi; G Viale
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

2.  Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative.

Authors:  S Shousha; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain.

Authors:  Weizhen Ye; Georges Mairet-Coello; Emanuel DiCicco-Bloom
Journal:  Histochem Cell Biol       Date:  2006-10-06       Impact factor: 4.304

4.  Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases.

Authors:  G Zamboni; F Bonetti; A Scarpa; G Pelosi; C Doglioni; A Iannucci; P Castelli; G Balercia; D Aldovini; A Bellomi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.

Authors:  G Saccani Jotti; S R Johnston; J Salter; S Detre; M Dowsett
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

6.  The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status.

Authors:  C Doglioni; A P Dei Tos; L Laurino; C Chiarelli; M Barbareschi; G Viale
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Proliferative activity is a significant prognostic factor in male breast carcinoma.

Authors:  A Pich; E Margaria; L Chiusa
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue.

Authors:  B Bier; A Bankfalvi; L Grote; S Blasius; D Ofner; W Böcker; B Jasani; K W Schmid
Journal:  Histochem J       Date:  1995-02

9.  Estrogen and progesterone receptors in thyroid lesions.

Authors:  B R Jaklic; J Rushin; B C Ghosh
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

10.  Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.

Authors:  A Pich; E Margaria; L Chiusa; G Candelaresi; O Dal Canton
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.